Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00039299
What this trial is testing

Biological Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00071968
What this trial is testing

Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 15
Not applicableStudy completedNCT00685516
What this trial is testing

Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT00714753
What this trial is testing

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 5
Testing effectiveness (Phase 2)WithdrawnNCT00598858
What this trial is testing

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+1 more
John P. Fruehauf
Large-scale testing (Phase 3)Study completedNCT00541047
What this trial is testing

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Who this might be right for
Gastrointestinal ComplicationsProstate CancerSexual Dysfunction+1 more
University College, London 4,236
Testing effectiveness (Phase 2)Study completedNCT00022399
What this trial is testing

Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 73
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Large-scale testing (Phase 3)Active Not RecruitingNCT03070886
What this trial is testing

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
NRG Oncology 612
Testing effectiveness (Phase 2)Study completedNCT00003394
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00054522
What this trial is testing

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01950351
What this trial is testing

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
M.D. Anderson Cancer Center 241
Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT06235151
What this trial is testing

Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Curium US LLC 439
Testing effectiveness (Phase 2)Study completedNCT00017563
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 57
Early research (Phase 1)Study completedNCT00054106
What this trial is testing

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 25
Testing effectiveness (Phase 2)Ended earlyNCT00073970
What this trial is testing

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 37
Early research (Phase 1)Study completedNCT00804245
What this trial is testing

C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Ended earlyNCT00753220
What this trial is testing

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bostwick Laboratories 7
Testing effectiveness (Phase 2)WithdrawnNCT06528210
What this trial is testing

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Who this might be right for
High Risk Prostate CarcinomaLocalized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
OHSU Knight Cancer Institute
Next Page